265 related articles for article (PubMed ID: 38765928)
1. Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria.
Danışman B; Ercan Kelek S; Aslan M
Psychiatry Clin Psychopharmacol; 2023 Jun; 33(2):147-155. PubMed ID: 38765928
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and Brain Mitochondria: a Review.
Jardim FR; de Rossi FT; Nascimento MX; da Silva Barros RG; Borges PA; Prescilio IC; de Oliveira MR
Mol Neurobiol; 2018 Mar; 55(3):2085-2101. PubMed ID: 28283884
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view.
de Oliveira MR; Nabavi SF; Manayi A; Daglia M; Hajheydari Z; Nabavi SM
Biochim Biophys Acta; 2016 Apr; 1860(4):727-45. PubMed ID: 26802309
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications.
Shaito A; Al-Mansoob M; Ahmad SMS; Haider MZ; Eid AH; Posadino AM; Pintus G; Giordo R
Curr Neuropharmacol; 2023; 21(5):1184-1201. PubMed ID: 36237161
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction.
Yadav E; Yadav P; Khan MMU; Singh H; Verma A
Front Pharmacol; 2022; 13():922232. PubMed ID: 36188541
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
13. Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration.
Solano Fonseca R; Metang P; Egge N; Liu Y; Zuurbier KR; Sivaprakasam K; Shirazi S; Chuah A; Arneaud SL; Konopka G; Qian D; Douglas PM
Elife; 2021 Sep; 10():. PubMed ID: 34473622
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Derivatives as Potential Treatments for Alzheimer's and Parkinson's Disease.
Arbo BD; André-Miral C; Nasre-Nasser RG; Schimith LE; Santos MG; Costa-Silva D; Muccillo-Baisch AL; Hort MA
Front Aging Neurosci; 2020; 12():103. PubMed ID: 32362821
[TBL] [Abstract][Full Text] [Related]
15. Role of traditional Chinese medicine in ameliorating mitochondrial dysfunction
Cai Z; Liu M; Zeng L; Zhao K; Wang C; Sun T; Li Z; Liu R
Front Pharmacol; 2023; 14():1123188. PubMed ID: 36937876
[TBL] [Abstract][Full Text] [Related]
16. Neurological disorders and mitochondria.
Cabral-Costa JV; Kowaltowski AJ
Mol Aspects Med; 2020 Feb; 71():100826. PubMed ID: 31630771
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondria in the regulation of neurodegenerative diseases: A comprehensive review.
Maurya SK; Gupta S; Bakshi A; Kaur H; Jain A; Senapati S; Baghel MS
J Neurosci Res; 2022 Oct; 100(10):1845-1861. PubMed ID: 35856508
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.
Franco-Iborra S; Vila M; Perier C
Front Neurosci; 2018; 12():342. PubMed ID: 29875626
[TBL] [Abstract][Full Text] [Related]
19. Effects of resveratrol on the rat brain respiratory chain.
Zini R; Morin C; Bertelli A; Bertelli AA; Tillement JP
Drugs Exp Clin Res; 1999; 25(2-3):87-97. PubMed ID: 10370869
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson's Disease.
Kung HC; Lin KJ; Kung CT; Lin TK
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
